Skip to main content
Premium Trial:

Request an Annual Quote

Deltadot Raises $6M Private Equity for R&D, Marketing

NEW YORK (GenomeWeb News) - Deltadot said today it has received £3 million ($6.1 million) to close a round of private equity funding that it will use to support R&D and marketing.
The company originally announced the funding round in March 2006. The financing announced today is the fourth and final tranche for the round and brings the total funds raised to £6 million ($12.2 million).
The funding was led by Fleming Family & Partners Private Equity, and included investments from Imperial Innovations, NPI Ventures, Sitka Health Fund VCT, and London Technology Fund.
Deltadot’s CEO, Anthony Baxter, said the molecular imaging company will use the capital to ramp up production of its Peregrine high-performance capillary electrophoresis system, to develop capillary and microfluidic technologies such as its Osprey system, and to develop international sales and marketing programs, particularly in the US.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.